Curative Biotechnology, Inc.
CUBT • Biotechnology
$0.66
▼ -0.04 (-6.41%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$4.83M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.01Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.66
Change-6.41%
Shares Out7.37M
Market Cap$4.83M
Enterprise Value$6.17M
52W Range0.03 - 1.99
Beta1.35
P/E-2.26
P/B-0.77
P/FCF-5.51
EV/EBITDA-4.28
EV/FCF-7.04
Price$0.66
Change-6.41%
Shares Out7.37M
Market Cap$4.83M
Enterprise Value$6.17M
52W Range0.03 - 1.99
Beta1.35
P/E-2.26
P/B-0.77
P/FCF-5.51
EV/EBITDA-4.28
EV/FCF-7.04
Earnings Yield-44.21%
FCF Yield-18.16%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.22
Current Ratio0.01
Quick Ratio0.01
Revenue 5Y-100.00%
Volume100.00
Avg Volume1.49K
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.01Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.